Health & Wellness
10/06/2026 · Pershing & Humboldt Region
Supreme Court Begins Term with Key Arguments, Denies Hundreds of Cases
The Supreme Court began its new term by hearing arguments in two cases on Monday, focusing on climate change liability and veterans' benefits. The court also denied review in hundreds of cases, including disputes over student speech and COVID-19 vaccine mandates. Future arguments will address retirement fund management and federal environmental laws.
Trump Administration Finalizes Healthcare Transparency Rule
The Trump administration has issued a final rule regarding transparency in healthcare coverage. Health and Human Services Secretary Robert F. Kennedy Jr. stated the regulation offers a 'clear view of what healthcare actually costs.' This initiative seeks to increase consumer understanding of medical expenses.
10/06/2026
Supreme Court Declines Cases on 'Let's Go Brandon' Apparel, Felon Gun Rights, and Vaccine Mandates
The Supreme Court initiated its 2026-27 term by issuing an order list from its September 28 private conference. Justices denied review in hundreds of cases, including those concerning student free speech, Second Amendment challenges for felons, and COVID-19 vaccine requirements.
10/06/2026
Bipartisan Concern Grows Over Pharmacy Benefit Managers
Republicans and Democrats alike are directing scrutiny toward pharmacy benefit managers, or PBMs. Tennessee and Arkansas have already implemented regulations targeting these healthcare companies. This convergence of political and public opinion highlights increasing pressure on PBM operations.
10/05/2026
Voters Seek Clear Policy Details, Economic Security from Candidates
Undecided voters express a desire for candidates to provide specific plans on issues affecting their daily lives. Economic stability and healthcare costs rank among their top concerns. Voters indicate they are looking for substantive proposals rather than broad ideological statements.
10/02/2026
Eli Lilly's EloraTZP Shows Greater Weight and A1C Reduction in Phase 2b Trial
Eli Lilly's experimental drug EloraTZP, a combination of eloralintide and tirzepatide, demonstrated superior weight loss and A1C reduction compared to tirzepatide 15 mg in a 48-week Phase 2b study. Participants taking EloraTZP lost significantly more weight and saw greater improvements in their blood sugar levels.
10/01/2026
Advertisement
Upcoming Events
View allOCT
05
Gym Closed for Private Event
12:00 AM - Free
OCT
06
Gym Closed for Private Event
12:00 AM - Free
OCT
07
Gym Closed for Private Event
12:00 AM - Free
Announcements
View allGovernor Lombardo Declares Liquid Petroleum Gas Delivery Emergency
Nevada Governor’s Office Press Releases | Official State News Skip Nav Newsroom Filter and Sort 271 Results Filter News 271 Total Number of Results Filter Events Date From To Apply Clear Filters Governor Lombardo Declares Liquid Petroleum Gas Delivery Emergency January 9, 2023 by Elizabeth Ray Scroll to Top
Advertisement
Advertisement
